WallStreetZenWallStreetZen

NASDAQ: TMDX
Transmedics Group Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TMDX past revenue growth

How has TMDX's revenue growth performed historically?
Company
158.53%
Industry
9.4%
Market
16.96%
TMDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TMDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TMDX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TMDX earnings and revenue history

Current Revenue
$241.6M
Current Earnings
-$25.0M
Current Profit Margin
-10.4%

TMDX Return on Equity

Current Company
-16.6%
Current Industry
10.5%
Current Market
188%
TMDX's Return on Equity (-16.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TMDX announces earnings.

TMDX Return on Assets

Current Company
-4.2%
Current Industry
5.3%
TMDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TMDX Return on Capital Employed

Current Company
-2.44%
Current Industry
8.3%
TMDX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TMDX vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TMDX$241.62M-$6.66M-$25.03M+79.36%N/A
LIVN$1.15B$38.38M$17.55M+0.83%N/A
QDEL$3.00B$575.70M-$10.10M+41.83%N/A
PRCT$136.19M-$98.08M-$105.90M+116.76%N/A
AXNX$366.38M$3.12M-$6.09M+249.06%N/A
View Top Medical Device Stocks

TMDX earnings dates

Next earnings date
Apr 29, 2024

Transmedics Group Earnings & Revenue FAQ

What were TMDX's earnings last quarter?

On Invalid Date, Transmedics Group (NASDAQ: TMDX) reported Q4 2023 earnings per share (EPS) of $0.12, up 160% year over year. Total Transmedics Group earnings for the quarter were $4.03 million. In the same quarter last year, Transmedics Group's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Transmedics Group stock.

What was TMDX's earnings growth in the past year?

As of Q2 2024, Transmedics Group's earnings has grown year over year. Transmedics Group's earnings in the past year totalled -$25.03 million.

What is TMDX's earnings date?

Transmedics Group's earnings date is Invalid Date. Add TMDX to your watchlist to be reminded of TMDX's next earnings announcement.

What was TMDX's revenue last quarter?

On Invalid Date, Transmedics Group (NASDAQ: TMDX) reported Q4 2023 revenue of $81.17 million up 158.72% year over year. In the same quarter last year, Transmedics Group's revenue was $31.38 million.

What was TMDX's revenue growth in the past year?

As of Q2 2024, Transmedics Group's revenue has grown 158.53% year over year. This is 149.14 percentage points higher than the US Medical Devices industry revenue growth rate of 9.4%. Transmedics Group's revenue in the past year totalled $241.62 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.